Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EcoEos is a precision health company focused on environmental toxicology and personalized risk assessment. The company developed the LeadRisk platform, which utilizes a proprietary algorithm to evaluate lead exposure risk in children and adults by integrating environmental data, lifestyle factors, and clinical history. This digital health solution aims to improve the efficiency of lead screening programs and facilitate early intervention to prevent the neurological and developmental damage associated with lead poisoning. By providing a data-driven risk score, EcoEos enables healthcare providers and parents to take proactive measures against toxic metal exposure. The company was founded by experts in pediatric lead poisoning and was part of the StartX accelerator program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecoeos.